GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (FRA:UNJ) » Definitions » 5-Year Yield-on-Cost %

United Laboratories International Holdings (FRA:UNJ) 5-Year Yield-on-Cost % : 3.16 (As of Apr. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings 5-Year Yield-on-Cost %?

United Laboratories International Holdings's yield on cost for the quarter that ended in Jun. 2023 was 3.16.


The historical rank and industry rank for United Laboratories International Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:

FRA:UNJ' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.74   Med: 1.53   Max: 4.53
Current: 3.16


During the past 13 years, United Laboratories International Holdings's highest Yield on Cost was 4.53. The lowest was 0.74. And the median was 1.53.


FRA:UNJ's 5-Year Yield-on-Cost % is ranked better than
60.32% of 499 companies
in the Drug Manufacturers industry
Industry Median: 2.22 vs FRA:UNJ: 3.16

Competitive Comparison of United Laboratories International Holdings's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's 5-Year Yield-on-Cost % falls into.



United Laboratories International Holdings 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of United Laboratories International Holdings is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

United Laboratories International Holdings  (FRA:UNJ) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


United Laboratories International Holdings 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (FRA:UNJ) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (FRA:UNJ) Headlines

No Headlines